Merck & Co. (MRK)
(Delayed Data from NYSE)
$103.09 USD
-0.46 (-0.44%)
Updated Dec 6, 2024 04:00 PM ET
After-Market: $103.66 +0.57 (0.55%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/04/2025
Time: BMO |
12/2024 | $1.85 | -4.23% |
Earnings Summary
For their last quarter, Merck & Co. (MRK) reported earnings of $1.57 per share, beating the Zacks Consensus Estimate of $1.50 per share. This reflects a positive earnings surprise of 4.67%. Look out for MRK's next earnings release on February 04, 2025. For the next earning release, we expect the company to report earnings of $1.85 per share, reflecting a year-over-year increase of 6066.67%.
Earnings History
Price & Consensus
Zacks News for MRK
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
MRK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Merck's ADC Drug Gets FDA Breakthrough Therapy Tag in NSCLC
Gilead Collaborates With German Biotech Tubulis for Solid Tumor ADC
J&J Seeks FDA Approval for Tremfya for Psoriasis in Kids
MRK FAQs
Merck & Co., Inc. (MRK) has announced they will report their next quarter earnings on February 04, 2025. For the next earning release, we expect the company to report earnings of $1.85 per share, reflecting a year-over-year increase of #######%.
Merck & Co., Inc. has announced they will report their previous quarter earnings after the close of the market on February 04, 2025.
The Zacks Consensus Estimate for Merck & Co., Inc. (MRK) for the quarter ending in December 2024 is $1.85 a share. We expect Merck & Co., Inc. to miss by -4.23%.
In the earnings report for the quarter ending in September 2024, Merck & Co., Inc. (MRK) announced earnings of $1.57 per share versus the Zacks Consensus Estimate of $1.50 per share, representing a surprise of 4.67%.